precision-firstTM

therapeutics

Rewriting the molecule-first
drug development model.

Delivering new precision
therapies to patients.

ABOUT US

building a

new kind of biopharma

We’re pioneering a new category
of precision medicine.

More
OUR APPROACH

patient-first

We’re flipping the molecule-first drug
development model on its head.

More
approach-video
PIPELINE

precision

immunology

Human biology is complex.
Immune-mediated diseases are personal.

More
New kind of biopharma together
PARTNERING

precision
immunology

ecosystem

We’re building the clinical and
data ecosystem to bring precision
immunology to patients.

More
CAREERS

let’s build a

new kind of
biopharma

together

Our company started with a simple question.
If you built a new biopharma company from
the ground up today, what would it look like?
The answer was Endpoint Health.

More
New kind of biopharma together
October 4, 2022

Endpoint Health Unveils Precision Immunology Program to Address Tissue Factor-Mediated Inflammation in Autoimmune Diseases